Journal
MOLECULAR NEURODEGENERATION
Volume 16, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13024-021-00502-y
Keywords
Basal lamina; Neurodegenerative disorders; Blood-Brain Barrier; Laminin; Perlecan
Categories
Funding
- American Heart Association Scientist Development Grant [R01HL146574, RF1AG065345, R21AG073862, R21AG064422]
- [16SDG29320001]
Ask authors/readers for more resources
This article focuses on the changes of the basal lamina (BL) during aging and in neurodegenerative disorders, and its impact on the blood-brain barrier and meningeal lymphatic/glymphatic system. Research has revealed the crucial role of the BL in the pathogenesis and progression of neurodegenerative disorders.
Background Neurodegenerative disorders are a group of age-associated diseases characterized by progressive degeneration of the structure and function of the CNS. Two key pathological features of these disorders are blood-brain barrier (BBB) breakdown and protein aggregation. Main body The BBB is composed of various cell types and a non-cellular component---the basal lamina (BL). Although how different cells affect the BBB is well studied, the roles of the BL in BBB maintenance and function remain largely unknown. In addition, located in the perivascular space, the BL is also speculated to regulate protein clearance via the meningeal lymphatic/glymphatic system. Recent studies from our laboratory and others have shown that the BL actively regulates BBB integrity and meningeal lymphatic/glymphatic function in both physiological and pathological conditions, suggesting that it may play an important role in the pathogenesis and/or progression of neurodegenerative disorders. In this review, we focus on changes of the BL and its major components during aging and in neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). First, we introduce the vascular and lymphatic systems in the CNS. Next, we discuss the BL and its major components under homeostatic conditions, and summarize their changes during aging and in AD, PD, and ALS in both rodents and humans. The functional significance of these alterations and potential therapeutic targets are also reviewed. Finally, key challenges in the field and future directions are discussed. Conclusions Understanding BL changes and the functional significance of these changes in neurodegenerative disorders will fill the gap of knowledge in the field. Our goal is to provide a clear and concise review of the complex relationship between the BL and neurodegenerative disorders to stimulate new hypotheses and further research in this field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available